최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Medical hypotheses, v.144, 2020년, pp.110216 -
Benny, Sonu (Corresponding author.) , Mishra, Rohan , Manojkumar, Maneesha K , Aneesh, T.P.
Abstract An old ideology of killing the cancer cells by starving them is the underlying concept of the Warburg effect. It is the process of aerobic glycolysis exhibited by the cancer cells irrespective of anaerobic glycolysis or mitochondrial oxidative phosphorylation following by their healthy cou...
Cancer Biol Ther Zhang 14 81 2013 10.4161/cbt.22958 Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention
10.1007/s10549-018-4691-4 Welch HG. The heterogeneity of cancer. vol. 169; 2018. https://doi.org/10.1007/s10549-018-4691-4.
Biomed Res Int Avagliano 2018 2018 10.1155/2018/6075403 Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts
Trends Cell Biol Hinohara 29 569 2019 10.1016/j.tcb.2019.03.003 Intratumoral Heterogeneity: More Than Just Mutations
Oncotarget Fu 8 57813 2017 10.18632/oncotarget.18175 The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy
J Mol Med Dang 89 205-12 2011 Therapeutic targeting of cancer cell metabolism
10.1038/nrd3504 Heiden MG vander. Targeting cancer metabolism: a therapeutic window opens. Nature Publishing Group; 10:671-84. https://doi.org/10.1038/nrd3504.
Cell Cycle Martinez-Outschoorn 10 4208 2011 10.4161/cc.10.24.18487 Energy transfer in “parasitic” cancer metabolism: Mitochondria are the powerhouse and Achilles’ heel of tumour cells
J Oncol Sci Fadaka 3 45 2017 10.1016/j.jons.2017.06.002 Biology of glucose metabolization in cancer cells
Sign Trans Targeted Therapy Hu 2 1 2017 Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation
Front Nutrit Goodwin 1 2014 2015 Lactate and Cancer: Revisiting the Warburg Effect in an Era of Lactate Shuttling
Front Pharmacol Porporato 2011 10.3389/fphar.2011.00049 Anticancer targets in the glycolytic metabolism of tumours: A comprehensive review
World J Biol Chem Lee 2015 10.4331/wjbc.v6.i3.148 Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication
Mol Carcinog Nakajima 2013 10.1002/mc.21863 Metabolic symbiosis in cancer: Refocusing the Warburg lens
Trends Cell Biol Manchester 5 384 1995 10.1016/S0962-8924(00)89080-7 Theodor Boveri and the origin of malignant tumours
Science Warburg 123 309 1956 10.1126/science.123.3191.309 On the origin of cancer cells
Science Heiden 324 1029 2009 10.1126/science.1160809 Understanding the Warburg effect: The metabolic requirements of cell proliferation
Carcinogenesis San-Millan 38 119 2017 Re-examining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect
Cancer Res Kim 66 8927-30 2006 Cancer’s molecular sweet tooth and the Warburg effect
Pharmacol Ther Upadhyay 137 318 2013 10.1016/j.pharmthera.2012.11.003 The Warburg effect: Insights from the past decade
Proteomics Clin Appl Scatena 2010 10.1002/prca.200900157 Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy
Biochim et Biophys Acta - Bioenergetics Danhier 1858 556 2017 10.1016/j.bbabio.2017.02.001 Cancer metabolism in space and time: Beyond the Warburg effect
Front Cell Dev Biol Bubici 7 1 2019 10.3389/fcell.2019.00080 Editorial: The Warburg effect regulation under siege: The intertwined pathways in health and disease
Mol Cancer Jing 18 1 2019 10.1186/s12943-019-1089-9 Role of hypoxia in cancer therapy by regulating the tumour microenvironment
Int J Radiat Biol Vaupel 95 912 2019 10.1080/09553002.2019.1589653 The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Semin Nephrol Spencer 2019 10.1016/j.semnephrol.2019.04.007 The Warburg Effect, Lactate, and Nearly a Century of Trying to Cure Cancer
Semin Oncol Wilde 44 198 2017 10.1053/j.seminoncol.2017.10.004 Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
Cell Cycle Witkiewicz 11 1108 2012 10.4161/cc.11.6.19530 Using the “reverse Warburg effect” to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers
J Exercise Physiol Online Crisp 18 1 2015 Lactate and Monocarboxylate Transporters (MCTs): A Review of Cellular Aspects
PLoS Comput Biol Shan 14 1 2018 10.1371/journal.pcbi.1006584 Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumours
Int J Radiat Oncol*Biol*Phys Boasquevisque 99 E579 2017 10.1016/j.ijrobp.2017.06.1994 Targeting Lactate Transporters MCT-1 and MCT-4 to Inhibit the Growth of Hypoxic HNSCC Cells In Vitro
Cell Reprogramm Mordhorst 2018 10.1089/cell.2017.0040 Pharmacologic Reprogramming Designed to Induce a Warburg Effect in Porcine Fetal Fibroblasts Alters Gene Expression and Quantities of Metabolites from Conditioned Media Without Increased Cell Proliferation
DMM Disease Mod Mechan Draoui 4 727 2011 10.1242/dmm.007724 Lactate shuttles at a glance: From physiological paradigms to anti-cancer treatments
Pleura Peritoneum Wilson 4 1 2019 10.1515/pp-2019-0003 Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes
Mol Cancer Ther Quanz 17 2285 2018 10.1158/1535-7163.MCT-17-1253 Preclinical efficacy of the novel monocarboxylate transporter 1 inhibitor BAY-8002 and associated markers of resistance
Int J Nanotechnol Sonal 2 1 2012 Nanomedicine: Promise Of The Future In Disease Management
J Clin Diagnos Res Sreelatha 12 2018 Prolonged remission and good quality of life with maintenance chemotherapy in recurrent ewing’s sarcoma
The Global Cancer Observatory G. Source: Globocan 2018. World Health Organization 2019; 876: 2018-9.
International Agency for Research on Cancer (IARC). New Global Cancer Data: GLOBOCAN 2018 | UICC. Geneva, Switzerland, 12 September 2018; 2018: 1-3.
Mol Cancer Ther Todenhofer 17 2746 2018 10.1158/1535-7163.MCT-18-0107 Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer
10.1073/pnas.95.7.3990 Pellerin L, Pellegri G, Martin JL, Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: Support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proceed Natl Acad Sci USA 1998; 95:3990-5. https://doi.org/10.1073/pnas.95.7.3990.
Acta Biomedica Chiu 83 168 2012 Towards a metabolic therapy of cancer?
Int J Mol Sci Roma-Rodrigues 20 2019 10.3390/ijms20040840 Targeting tumor microenvironment for cancer therapy
ISRN Biochemistry Tsai 2014 1 2014 10.1155/2014/351959 Tumor Microenvironment: A New Treatment Target for Cancer
Indian J Dermatol, Venereol Leprol Jose 80 82 2014 10.4103/0378-6323.125486 Revisiting cutaneous metastasis from carcinoma gall bladder
Front Oncol Morrot 8 1 2018 10.3389/fonc.2018.00081 Metabolic symbiosis and immunomodulation: How tumor cell-derived lactate may disturb innate and adaptive immune responses
Eur Rev Med Pharmacol Sci Wang 22 3855 2018 Tumor microenvironment: Recent advances in various cancer treatments
Science Hodge 5 363 1990 The Metabolic Requirements of Cell Proliferation
J Thora Oncol Kobayashi 2 808 2007 10.1097/JTO.0b013e31814617c7 Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less
Cancer Therapy Adv Blevins Primeau 1 2018 A. Cancer recurrence statistics
Tumor Microenviron Therapy Takebe 1 2013 10.2478/tumor-2013-0001 Review of Cancer - Associated Fibroblasts and Therapies that Interfere with Their Activity
J Exp Clin Cancer Res Yoshida 34 1 2015 10.1186/s13046-015-0221-y Metabolic reprogramming: The emerging concept and associated therapeutic strategies
Biochim et Biophys Acta - Mol Cell Res Perez-Escuredo 2016 10.1016/j.bbamcr.2016.03.013 Monocarboxylate transporters in the brain and in cancer
Cancer Genom Proteom Gorska-Ponikowska 14 483 2017 2-Methoxyestradiol Reverses the Pro-Carcinogenic Effect of L-Lactate in Osteosarcoma 143B Cells
Sci Rep da Veiga 9 1 2019 Metabolic therapies inhibit tumor growth in vivo and in silico
Mol Aspects Med Halestrap 34 337 2013 10.1016/j.mam.2012.05.003 The SLC16 gene family-Structure, role and regulation in health and disease
Cancer Cell Int Guo 19 1 2019 10.1186/s12935-019-0889-8 Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
PLoS Biol Haas 13 2015 10.1371/journal.pbio.1002202 Lactate regulates metabolic and proinflammatory circuits in control of T cell migration and effector functions
10.1016/B978-0-12-394316-3.00009-0 Adijanto J, Philp NJ. The SLC16A family of monocarboxylate transporters (MCTs)-physiology and function in cellular metabolism, pH homeostasis, and fluid transport. vol. 70. Elsevier; 2012. doi: 10.1016/B978-0-12-394316-3.00009-0.
Anticancer Res Gotanda 33 2941 2013 Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor
BMC Clin Pathol Latif 17 1 2017 10.1186/s12907-017-0067-7 Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
Oncol Rev Javaeed 13 88 2019 10.4081/oncol.2019.403 MCT4 has a potential to be used as a prognostic biomarker - A systematic review and meta-analysis
Mol Membr Biol Manoharan 2006 10.1080/09687860600841967 The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity
ACS Med Chem Lett Gurrapu 6 558 2015 10.1021/acsmedchemlett.5b00049 Monocarboxylate transporter 1 inhibitors as potential anticancer agents
Cancer Res Gallagher 2007 10.1158/0008-5472.CAN-06-3184 Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231
Clin Exp Metastasis Chen 2010 10.1007/s10585-010-9345-9 Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.